Blood Donation and Victoza (Victoza/Liraglutide): Eligibility & Guidelines

Donating Blood While Taking Liraglutide (Victoza®)

Liraglutide is a GLP‑1 receptor agonist for type 2 diabetes. The FDA does not prohibit blood donation solely based on this medication. Eligibility hinges on the donor’s overall health and glycemic control.

General Diabetes Donation Criteria (Red Cross / AABB)

  • Diabetes well‑controlled (HbA1c <8% preferred, no recent DKA/HHS).
  • No diabetic complications requiring vascular surgery, amputation, or active ulceration.
  • Not on insulin? No deferral. On insulin? Acceptable if stable.
  • No bovine insulin exposure since 1980 (vCJD risk).

Victoza‑Specific Considerations

  • Liraglutide is not a blood‑borne pathogen risk.
  • Some centers may ask about recent dose changes or hypoglycemia episodes.
  • Injection‑site reactions (bruising) should be healed before phlebotomy.

Steps Before Donating

  1. Call the donation center (Red Cross: 1‑800‑RED‑CROSS) and disclose medication.
  2. Bring medication list; know your last HbA1c.
  3. Hydrate well; eat a balanced meal before appointment.
  4. If deferred, ask for specific reason and re‑eligibility timeline.

Most stable type 2 diabetics on GLP‑1 agonists donate successfully.

Blood Disorders - Related Articles